子痫前期血脑屏障完整性与神经炎症的评估
该观察性病例对照研究纳入48名>24周孕妇,比较子痫前期、健康妊娠及慢性或妊娠期高血压组,发现子痫前期患者脑脊液/血浆白蛋白比值(Qalb)及脑脊液C5a、C5b-9、肿瘤坏死因子-α、白介素-6均未升高,无血脑屏障受损或神经炎症证据。
要点
- 子痫前期患者Qalb中位数3.5(IQR 2.9-5.1),与健康及高血压对照组3.9(IQR 3.0-4.8)比较无统计学差异(P=.78)。
- 子痫前期伴严重特征者Qalb中位数3.5(IQR 3.3-4.9),与不伴严重特征者3.7(IQR 2.3-5.5)比较无统计学差异(P=.62)。
- 子痫前期患者脑脊液C5a、C5b-9、肿瘤坏死因子-α、白介素-6均未较对照组升高(所有比较P>.05)。
核心结论
- 通过检测分娩时配对的血液和脑脊液样本中的白蛋白、补体蛋白和细胞因子,未发现子痫前期患者存在血脑屏障受损或神经炎症的证据。
- 作者建议开展更大规模、检测更广泛蛋白种类的研究以验证上述发现。
研究设计与样本
- 观察性病例对照研究,纳入>24周妊娠、因择期剖宫产接受腰麻或分娩接受腰硬联合镇痛的孕妇。
- 共纳入48名受试者,包括16例子痫前期病例、16例健康妊娠对照和16例慢性或妊娠期高血压对照。
- 分娩前采集每名受试者配对的血液、尿液和脑脊液样本。
- 采用比色法或酶联免疫吸附试验检测血浆和脑脊液中的白蛋白、C5a、C5b-9、肿瘤坏死因子-α和白介素-6浓度,以及尿液中的白蛋白、C5a和C5b-9浓度。
- 以脑脊液与血浆白蛋白比值(Qalb)作为母体血脑屏障完整性的替代指标,以脑脊液中C5a、C5b-9、肿瘤坏死因子-α和白介素-6浓度作为神经炎症的替代标志物。
主要发现
- 子痫前期病例Qalb中位数3.5(四分位距2.9-5.1),健康妊娠对照3.9(四分位距3.0-4.8),慢性或妊娠期高血压对照3.9(四分位距3.0-4.8),三组比较P=.78。
- 子痫前期伴严重特征者(n=8)Qalb中位数3.5(四分位距3.3-4.9),不伴严重特征者(n=8)3.7(四分位距2.3-5.5),两组比较P=.62。
- 子痫前期病例脑脊液中C5a、C5b-9、肿瘤坏死因子-α和白介素-6浓度较健康妊娠、慢性高血压或妊娠期高血压对照均未升高(所有比较P>.05)。
- 与脑脊液阴性结果相反,子痫前期病例血浆C5b-9和白介素-6浓度以及尿液C5a和C5b-9浓度升高。
局限性
- 作者建议开展更大规模的研究并检测更广泛的蛋白种类以验证本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although blood-brain barrier integrity is intact under normal pregnancy conditions, animal studies suggest that blood-brain barrier impairment occurs in preeclampsia. Yet, human data are limited, and the integrity of the blood-brain barrier has not been assessed in women with preeclampsia. OBJECTIVE: We sought to test the hypothesis that the integrity of the blood-brain barrier is impaired and that neuroinflammation is increased in women with preeclampsia. STUDY DESIGN: We performed an observational case-control study in pregnant women >24 weeks gestation who underwent spinal anesthesia for elective cesarean delivery or combined spinal epidural analgesia for labor. Cases were women with preeclampsia, and control subjects were women with either healthy pregnancy, chronic hypertension, or gestational hypertension. Paired samples of blood, urine, and cerebrospinal fluid were collected from each subject before delivery. We measured albumin, C5a, C5b-9, tumor necrosis factor-α, and interleukin-6 concentrations in plasma and cerebrospinal fluid, and albumin, C5a, and C5b-9 concentrations in urine, using colorimetric or enzyme-linked immunosorbent assays. The ratio of albumin in cerebrospinal fluid to plasma (Qalb) was used as a surrogate for maternal blood-brain barrier integrity. Cerebrospinal fluid concentrations of C5a, C5b-9, tumor necrosis factor-α, and interleukin-6 were used as surrogate markers of neuroinflammation. Differences in Qalb and cerebrospinal fluid protein concentrations between groups were assessed by nonparametric test of medians. RESULTS: Forty-eight subjects were enrolled, which included 16 cases with preeclampsia, 16 control subjects with healthy pregnancy, and 16 control subjects with either chronic or gestational hypertension. Qalb values were not increased in preeclampsia cases compared with healthy or hypertensive control subjects (Qalb median, 3.5 [interquartile range, 2.9-5.1] vs 3.9 [interquartile range, 3.0-4.8] vs 3.9 [interquartile range, 3.0-4.8]; P=.78]. Moreover, Qalb values were not increased in the subset of women with preeclampsia with severe features (n=8) compared with those without severe features (n=8; Qalb median, 3.5 [interquartile range, 3.3-4.9] vs 3.7 [interquartile range, 2.3-5.5]; P=.62]. Cerebrospinal fluid concentrations of C5a, C5b-9, tumor necrosis factor-α and interleukin-6 were not increased in cases of preeclampsia, compared with control subjects with either healthy pregnancy, chronic hypertension, or gestational hypertension (P>.05, all comparisons). In contrast to the negative findings in cerebrospinal fluid, plasma concentrations of both C5b-9 and interleukin-6 and urine concentrations of C5a and C5b-9 were increased in cases of preeclampsia. CONCLUSION: Through measurements of albumin, complement proteins, and cytokines in paired samples of blood and cerebrospinal fluid at the time of delivery, we found no evidence of blood-brain barrier impairment or neuroinflammation in preeclampsia. Larger studies that will investigate a wider range of proteins are suggested to validate our findings.
引用
- Burwick RM, Togioka BM, Speranza RJ, et al. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia. Am J Obstet Gynecol. 2019. PMID: 31229428. doi:10.1016/j.ajog.2019.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。